Skip to Content

Sen. Warren Urges FDA to Finalize GMO Labeling Guidelines

Calls for FDA to implement policies to promote transparency for consumers

Aug 27, 2013

WASHINGTON, DC -United States Senator Elizabeth Warren (D-MA) and Senator Mark Udall (D-CO) have sent a letter to the Food and Drug Administration (FDA) urging the agency to finalize its policies on the labeling of genetically modified organisms (GMOs) marketed as food products or additives.

"We encourage the FDA to implement a regulatory framework that will promote transparency for consumers while providing producers with the certainty they need to label their products appropriately," Senators Warren and Udall write in the letter. "Standardized labels will prevent misleading or confusing information from being presented to consumers which will help them make informed purchasing decisions that will encourage market competition."

The full text of the letter is available here.

Boston Office

2400 JFK Federal Building

15 New Sudbury Street

Boston, MA 02203

Phone: (617) 565-3170

Springfield Office

1550 Main Street

Suite 406

Springfield, MA 01103

Phone: (413) 788-2690

Washington Office

317 Hart Senate Office Building

Washington, DC 20510

Phone: (202) 224-4543